TINA BUMGARNER: Open Payments
NPI 1598932683 · CAROLINA SHORES, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$98 in 6 payments from 5 companies in 2025. Trend: 2023 $644 · 2024 $214 · 2025 $98
Food & beverage: $98
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| ABBVIE INC. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: FARXIGA, VRAYLAR, Veozah, XIFAXAN, OTEZLA.
Industry payments across NC — which companies pay providers there.
